The update on transcriptional regulation of autophagy in normal and pathologic cells: A novel therapeutic target

Biomedicine and Pharmacotherapy

Volumn 74, Issue , 2015, Pages 17-29

  Zhang, Zili ^a   Guo, Mei ^b   Zhao, Shifeng ^a   Xu, Wenxuan ^a   Shao, Jiangjuan ^a   Zhang, Feng ^a   Wu, Li ^a   Lu, Yin ^a   Zheng, Shizhong ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Autophagy; Therapeutic target; Transcription factors; Transcriptional regulation

Indexed keywords

FARNESOID X RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN P53; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR EB; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR GATA; UNCLASSIFIED DRUG;

AUTOPHAGOSOME; AUTOPHAGY; BIOGENESIS; CELL FUNCTION; HUMAN; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MOLECULARLY TARGETED THERAPY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; GENE EXPRESSION REGULATION; HUMANS; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84940887447     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2015.06.003     Document Type: Review

References (186)

1. Hurley J.H., Schulman B.A. Atomistic autophagy: the structures of cellular self-digestion. Cell 2014, 157:300-311.
2. Rabinowitz J.D., White E. Autophagy and metabolism. Science 2010, 330:1344-1348.
3. Mizushima N., Levine B., Cuervo A.M., Klionsky D.J. Autophagy fights disease through cellular self-digestion. Nature 2010, 451:1069-1075.
4. Hale A.N., Ledbetter D.J., Gawriluk T.R. Autophagy: regulation and role in development. Autophagy 2013, 9:951-972.
5. Sato K., Tsuchihara K., Fujii S., Sugiyama M., Goya T., Atomi Y., et al. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation. Cancer Res. 2007, 67:9677-9684.
6. Slavikova S., Ufaz S., Avin-Wittenberg T., Levanony H., Galili G. An autophagy-associated Atg8 protein is involved in the responses of Arabidopsis seedlings to hormonal controls and abiotic stresses. J. Exp. Bot. 2008, 59:4029-4043.
7. Zhang X., Yang Y., Liang X., Zeng X., Liu Z., Tao W., et al. Enhancing therapeutic effects of docetaxel-loaded dendritic copolymer nanoparticles by co-treatment with autophagy inhibitor on breast cancer. Theranostics 2014, 4:1085-1095.
8. Marchiando A.M., Ramanan D., Ding Y., Gomez L.E., Hubbard-Lucey V.M., Maurer K., et al. A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host. Microbe 2013, 14:216-224.
9. Hyttinen J.M., Amadio M., Viiri J., Pascale A., Salminen A., Kaarniranta K. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases. Ageing Res. Rev. 2014, 18:16-28.
10. Tanaka A. Parkin-mediated selective mitochondrial autophagy, mitophagy: Parkin purges damaged organelles from the vital mitochondrial network. FEBS Lett. 2010, 584:1386-1392.
11. Schmidt R.S., Butikofer P. Autophagy in Trypanosoma brucei: amino acid requirement and regulation during different growth phases. PLoS One 2014, 9:e93875.
12. Awan M.U., Deng Y. Role of autophagy and its significance in cellular homeostasis. Appl. Microbiol. Biotechnol. 2014, 98:5319-5328.
13. Ching J.K., Elizabeth S.V., Ju J.S., Lusk C., Pittman S.K., Weihl C.C. mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum. Mol. Genet. 2013, 22:1167-1179.
14. Ebrahimi-Fakhari D., Wahlster L., Hoffmann G.F., Kölker S. Emerging role of autophagy in pediatric neurodegenerative and neurometabolic diseases. Pediatr. Res. 2014, 75:217-226.
15. Thompson D.A., Klionsky D.J. Autophagy and gene therapy combine in the treatment of liver disease. Autophagy 2014, 9:945-946.
16. Kenific C.M., Debnath J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol. 2015, 25:37-45.
17. Cui J., Gong Z., Shen H.M. The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets. Biochim. Biophys. Acta 2013, 1836:15-26.
18. Klionsky D.J., Codogno P. The mechanism and physiological function of macroautophagy. J. Innate Immun. 2013, 5:427-433.
19. Kelekar A. Autophagy. Ann. N Y Acad. Sci. 2005, 1066:259-271.
20. Lazarus M.B., Novotny C.J., Shokat K.M. Structure of the human autophagy initiating kinase ULK1 in complex with potent inhibitors. ACS Chem. Biol. 2015, 10:257-261.
21. Yu L., McPhee C.K., Zheng L., Mardones G.A., Rong Y., Peng J., et al. Termination of autophagy and reformation of lysosomes regulated by mTOR. Nature 2010, 465:942-946.
22. Lee J.M., Wagner M., Xiao R., Kim K.H., Feng D., Lazar M.A., et al. Nutrient-sensing nuclear receptors coordinate autophagy. Nature 2014, 516:112-115.
23. Settembre C., Ballabio A. Cell metabolism: autophagy transcribed. Nature 2014, 516:40-41.
24. Seok S., Fu T., Choi S.E., Li Y., Zhu R., Kumar S., et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 2014, 516:108-111.
25. Li S., Ni A., Feng G. Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis. Acta Pharmacol. Sin. 2015, 36:113-118.
26. Gadaleta R.M., Cariello M., Sabba C., Moschetta A. Tissue-specific actions of FXR in metabolism and cancer. Biochim. Biophys. Acta 2015, 1851:30-39.
27. Schmitt J., Kong B., Stieger B., Tschopp O., Schultze S.M., Rau M., et al. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal. Liver Int. 2015, 10.1111/liv.12456.
28. Yang Z.X., Shen W., Sun H. Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease. Hepatol. Int. 2010, 4:741-748.
29. Jiao Y., Lu Y., Li X. Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol. Sin. 2015, 36:44-50.
30. Prawitt J., Abdelkarim M., Stroeve J.H., Popescu I., Duez H., Velagapudi V.R., et al. Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes 2011, 60:1861-1871.
31. Miyata M., Matsuda Y., Nomoto M., Takamatsu Y., Sato N., Hamatsu M., et al. Cholesterol feeding prevents hepatic accumulation of bile acids in cholic acid-fed farnesoid X receptor (FXR)-null mice: FXR-independent suppression of intestinal bile acid absorption. Drug Metab. Dispos. 2009, 37:338-344.
32. Ding L., Yang Y., Qu Y., Yang T., Wang K., Liu W., et al. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats. Mol. Med. Rep. 2015, 3270. doi:10.3892/mmr.2015.
33. Mazuy C., Helleboid A., Staels B., Lefebvre P. Nuclear bile acid signaling through the farnesoid X receptor. Cell Mol. Life Sci. 2015, 72:1631-1650.
34. Belghit I., Panserat S., Sadoul B., Dias K., Skiba-Cassy S., Seiliez I. Macronutrient composition of the diet affects the feeding-mediated downregulation of autophagy in muscle of rainbow trout (O. mykiss). PLoS One 2013, 8:e74308.
35. Papackova Z., Dankova H., Palenickova E., Kazdová L., Cahová M. Effect of short- and long-term high-fat feeding on autophagy flux and lysosomal activity in rat liver. Physiol. Res. 2012, 61:S67-S76.
36. Manley S., Ni H.M., Williams J.A., Kong B., DiTacchio L., Guo G., et al. Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity. Redox Biol. 2014, 2:991-1002.
37. Manley S., Ni H.M., Kong B., Apte U., Guo G., Ding W.X. Suppression of autophagic flux by bile acids in hepatocytes. Toxicol. Sci. 2014, 137:478-490.
38. Williams J.A., Thomas A.M., Li G., Kong B., Zhan L., Inaba Y., et al. Tissue specific induction of p62/Sqstm1 by farnesoid X receptor. PLoS One 2012, 7:e43961.
39. Lee J., Seok S., Yu P., Kim K., Smith Z., Rivas-Astroza M., et al. Genomic analysis of hepatic farnesoid X receptor binding sites reveals altered binding in obesity and direct gene repression by farnesoid X receptor in mice. Hepatology 2012, 56:108-117.
40. Aleshin S., Reiser G. Role of the peroxisome proliferator-activated receptors (PPAR)-alpha, beta/delta and gamma triad in regulation of reactive oxygen species signaling in brain. Biol. Chem. 2013, 394:1553-1570.
41. Schmuth M., Moosbrugger-Martinz V., Blunder S., Dubrac S. Role of PPAR, LXR, and PXR in epidermal homeostasis and inflammation. Biochim. Biophys. Acta 2014, 1841:463-473.
42. Aleshin S., Strokin M., Sergeeva M., Reiser G. Peroxisome proliferator-activated receptor (PPAR)beta/delta, a possible nexus of PPAR alpha- and PPAR gamma-dependent molecular pathways in neurodegenerative diseases: review and novel hypotheses. Neurochem. Int. 2013, 63:322-330.
43. Zhirov I.V., Zaseeva A.V., Masenko V.P., Tereshchenko S.N. Peroxisome proliferator-activated receptors-alpha (PPAR-alpha) and chronic heart failure: is there a reason to discuss the metabolic strategy of treatment?. Ter. Arkh. 2014, 86:78-82.
44. Coll T., Rodriguez-Calvo R., Barroso E. Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome. Curr. Mol. Pharmacol. 2009, 2:46-55.
45. Janani C., Ranjitha Kumari B.D. PPAR gamma gene - a review. Diabet. Metab. Syndr. 2015, 9:46-50.
46. Chon S.H., Tannahill R., Yao X., Southall M.D., Pappas A. Keratinocyte differentiation and upregulation of ceramide synthesis induced by an oat lipid extract via the activation of PPAR pathways. Exp. Dermatol. 2015, 24:290-295.
47. Zoccal K.F., Paula-Silva F.W., Bitencourt Cda S., Sorgi C.A., Bordon Kde C., Arantes E.C., et al. PPAR-gamma activation by Tityus serrulatus venom regulates lipid body formation and lipid mediator production. Toxicon 2015, 93:90-97.
48. Zheng J., Xiao X., Zhang Q., Yu M., Xu J., Wang Z. Maternal high-fat diet modulates hepatic glucose, lipid homeostasis and gene expression in the PPAR pathway in the early life of offspring. Int. J. Mol. Sci. 2014, 15:14967-14983.
49. Kumar P.M., Venkataranganna M.V., Manjunath K., Viswanatha G.L., Ashok G. Methanolic extract of Momordica cymbalaria enhances glucose uptake in L6 myotubes in vitro by upregulating PPAR-gamma and GLUT-4. Chin. J. Nat. Med. 2014, 12:895-900.
50. Liu Y.R., Hu T.M., Lan T., Chiu H.J., Chang Y.H., Chen S.F., et al. Association of the PPAR-gamma gene with altered glucose levels and psychosis profile in schizophrenia patients exposed to antipsychotics. Psychiatry Invest. 2014, 11:179-185.
51. Lefebvre P., Chinetti G., Fruchart J.C., Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J. Clin. Invest. 2006, 116:571-580.
52. Wilbanks M.S., Gust K.A., Atwa S., Sunesara I., Johnson D., Ang C.Y., et al. Validation of a genomics-based hypothetical adverse outcome pathway: 2,4-dinitrotoluene perturbs PPAR signaling thus impairing energy metabolism and exercise endurance. Toxicol. Sci. 2014, 141:44-58.
53. Ji P., Drackley J.K., Khan M.J., Loor J.J. Overfeeding energy upregulates peroxisome proliferator-activated receptor (PPAR) gamma-controlled adipogenic and lipolytic gene networks but does not affect proinflammatory markers in visceral and subcutaneous adipose depots of Holstein cows. J. Dairy Sci. 2014, 97:3431-3440.
54. Keshet R., Bryansker Kraitshtein Z., Shanzer M., Adler J., Reuven N., Shaul Y. c-Abl tyrosine kinase promotes adipocyte differentiation by targeting PPAR-gamma 2. Proc. Natl. Acad. Sci. U S A 2014, 111:16365-16370.
55. Kitamura T., Kitamura Y. The roles of PPAR C/EBP and FoxO families in adipocyte differentiation and proliferation. Nihon Rinsho 2011, 69:259-263.
56. McCarthy C., Lieggi N.T., Barry D., Mooney D., de Gaetano M., James W.G., et al. Macrophage PPAR gamma co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid. EMBO Mol. Med. 2013, 5:1443-1457.
57. Diaz-Gandarilla J.A., Osorio-Trujillo C., Hernandez-Ramirez V.I., Talamás-Rohana P. PPAR activation induces M1 macrophage polarization via cPLA(2)-COX-2 inhibition, activating ROS production against Leishmania Mexicana. Biomed. Res. Int. 2013, 2013:215283.
58. Bassaganya-Riera J., Viladomiu M., Pedragosa M., De Simone C., Carbo A., Shaykhutdinov R., et al. Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPARγ to suppress colitis. PLoS One 2012, 7:e31238.
59. Duval C., Fruchart J.C., Staels B. PPAR alpha, fibrates, lipid metabolism and inflammation. Arch. Mal. Coeur Vaiss. 2004, 97:665-672.
60. Jia Y., Kim S., Kim J., Kim B., Wu C., Lee J.H., et al. Ursolic acid improves lipid and glucose metabolism in high-fat-fed C57BL/6J mice by activating peroxisome proliferator-activated receptor alpha and hepatic autophagy. Mol. Nutr. Food Res. 2015, 59:344-354.
61. Jiao M., Ren F., Zhou L., Duan Z., Zhao C. Roles of peroxisome proliferator-activated receptor-alpha in acute liver failure and its pathogenetic mechanism in mice. Zhonghua Yi Xue Za Zhi 2014, 94:2059-2063.
62. Baena M., Sanguesa G., Hutter N., Sánchez R.M., Roglans N., Laguna J.C., et al. Fructose supplementation impairs rat liver autophagy through mTORC activation without inducing endoplasmic reticulum stress. Biochim. Biophys. Acta 2015, 1851:107-116.
63. Kim K., Pyo S., Um S.H. S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology 2012, 55:1727-1737.
64. Das N.R., Gangwal R.P., Damre M.V., Sangamwar A.T., Sharma S.S. A PPAR-beta/delta agonist is neuroprotective and decreases cognitive impairment in a rodent model of Parkinson's disease. Curr. Neurovasc. Res. 2014, 11:114-124.
65. Palomer X., Capdevila-Busquets E., Botteri G., Salvadó L., Barroso E., Davidson M.M., et al. PPAR beta/delta attenuates palmitate-induced endoplasmic reticulum stress and induces autophagic markers in human cardiac cells. Int. J. Cardiol. 2014, 174:110-118.
66. O'Sullivan S.E., Kendall D.A. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology 2010, 215:611-616.
67. Fedorova L.V., Sodhi K., Gatto-Weis C., Puri N., Hinds T.D., Shapiro J.I., et al. Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia. PLoS One 2013, 8:e64436.
68. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
69. Jonker J.W., Suh J.M., Atkins A.R., Ahmadian M., Li P., Whyte J., et al. A PPARgamma-FGF1 axis is required for adaptive adipose remodeling and metabolic homeostasis. Nature 2012, 485:391-394.
70. Malaviya A., Sylvester P. Synergistic antiproliferative effects of combined gamma-tocotrienol and PPAR gamma antagonist treatment are mediated through PPAR gamma-independent mechanisms in breast cancer cells. PPAR Res. 2014, 439146.
71. Woo C.C., Loo S.Y., Gee V., Yap C.W., Sethi G., Kumar A.P., et al. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-gamma pathway. Biochem. Pharmacol. 2011, 82:464-475.
72. Ueno T., Teraoka N., Takasu S., Nakano K., Takahashi M., Yamamoto M., et al. Suppressive effect of pioglitazone, a PPAR gamma ligand, on azoxymethane-induced colon aberrant crypt foci in KK-Ay mice. Asian Pac. J. Cancer Prev. 2012, 13:4067-4073.
73. Choi I.K., Kim Y.H., Kim J.S., Seo J.H. PPAR-gamma ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivo. Invest New Drugs 2008, 26:283-288.
74. Yamazaki K., Shimizu M., Okuno M., Matsushima-Nishiwaki R., Kanemura N., Araki H., et al. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells - phosphorylated RXR alpha is a critical target for colon cancer management. Gut 2007, 56:1557-1563.
75. Shen Y., Sun Z., Guo X. Citral inhibits lipopolysaccharide-induced acute lung injury by activating PPAR-gamma. Eur. J. Pharmacol. 2015, 747:45-51.
76. Ma Z., Ji W., Fu Q., Ma S. Formononetin inhibited the inflammation of LPS-induced acute lung injury in mice associated with induction of PPAR gamma expression. Inflammation 2013, 36:1560-1566.
77. Wang Y.X., Zhu W.J., Xie B.G. Expression of PPAR-gamma in adipose tissue of rats with polycystic ovary syndrome induced by DHEA. Mol. Med. Rep. 2014, 9:889-893.
78. Zhang H., Bi Y., Hu C., Lu W., Zhu D. Association between the Pro12Ala polymorphism of PPAR-gamma gene and the polycystic ovary syndrome: a meta-analysis of case-control studies. Gene 2012, 503:12-17.
79. Rogenhofer S., Ellinger J., Kahl P., Stoehr C., Hartmann A., Engehausen D., et al. Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-gamma) in advanced prostate cancer. Anticancer Res. 2014, 32:3479-3483.
80. Bolden A., Bernard L., Jones D., Akinyeke T., Stewart L.V., The P.P.A.R. Gamma agonist troglitazone regulates Erk1/2 phosphorylation via a PPARgamma-independent, MEK-dependent pathway in human prostate cancer cells. PPAR Res. 2012, 929052.
81. Raman P., Koenig R.J. Pax-8-PPAR-gamma fusion protein in thyroid carcinoma. Nat. Rev. Endocrinol. 2014, 10:616-623.
82. Sharifah N.A., Zakaria Z., Chia WK.FISH. analysis using PPAR gamma-specific probes for detection of PAX8-PPAR gamma translocation in follicular thyroid neoplasms. Methods Mol. Biol. 2013, 952:187-196.
83. Doshi L.S., Brahma M.K., Bahirat U.A., Dixit A.V., Nemmani K.V. Discovery and development of selective PPAR gamma modulators as safe and effective antidiabetic agents. Expert Opin. Investig. Drugs 2011, 19:489-512.
84. Dicitore A., Caraglia M., Gaudenzi G., Manfredi G., Amato B., Mari D., et al. Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-gamma (PPAR-gamma): at the crossroad of pancreatic cancer cell proliferation. Biochim. Biophys. Acta 2014, 1845:42-52.
85. Levytska K., Drewlo S., Baczyk D., Kingdom J. PPAR-gamma regulates trophoblast differentiation in the BeWo cell model. PPAR Res. 2014, 2014:637251.
86. Small D.M., Morais C., Coombes J.S., Bennett N.C., Johnson D.W., Gobe G.C. Oxidative stress induced alterations in PPAR-gamma and associated mitochondrial destabilization contribute to kidney cell apoptosis. Am. J. Physiol. Renal Physiol. 2014, 307:F814-F822.
87. Pedersen G. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Dan. Med. J. 2015, 62:B4973.
88. Yan S., Yang X., Chen T., Xi Z., Jiang X. The PPAR gamma agonist troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Cancer Gene Ther. 2014, 21:188-193.
89. Pellerito O., Notaro A., Sabella S., De Blasio A., Vento R., Calvaruso G., et al. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARgamma downregulation. Apoptosis 2014, 19:1029-1042.
90. Tsukahara T., Matsuda Y., Haniu H. PSF knockdown enhances apoptosis via downregulation of LC3B in human colon cancer cells. Biomed. Res. Int. 2013, 2013:204973.
91. Vara D., Morell C., Rodriguez-Henche N., Diaz-Laviada I. Involvement of PPAR gamma in the antitumoral action of cannabinoids on hepatocellular carcinoma. Cell Death Dis. 2013, 4:e618.
92. Avena P., Anselmo W., Whitaker-Menezes D., Wang C., Pestell R.G., Lamb R.S., et al. Compartment-specific activation of PPAR gamma governs breast cancer tumor growth, via metabolic reprogramming and symbiosis. Cell Cycle 2013, 12:1360-1370.
93. Rovito D., Giordano C., Vizza D., Plastina P., Barone I., Casaburi I., et al. Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARgamma activation in MCF-7 breast cancer cells. J. Cell Physiol. 2013, 228:1314-1322.
94. Qin H., Tan W., Zhang Z., Bao L., Shen H., Wang F., et al. 15d-Prostaglandin J protects cortical neurons against oxygen-glucose deprivation/reoxygenation injury: involvement of inhibiting autophagy through upregulation of Bcl-2. Cell Mol. Neurobiol. 2014, 35:303-312.
95. Xu F., Li J., Ni W., Shen Y.W., Zhang X.P. Peroxisome proliferator-activated receptor-gamma agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury. PLoS One 2013, 8:e55080.
96. Corona J.C., de Souza S.C., Duchen M.R. PPAR gamma activation rescues mitochondrial function from inhibition of complex I and loss of PINK1. Exp. Neurol. 2014, 253:16-27.
97. Strand D.W., Jiang M., Murphy T.A., Yi Y., Konvinse K.C., Franco O.E., et al. PPAR gamma isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation. Cell Death Dis. 2012, 3:e361.
98. Ebrahimi-Fakhari D., Wahlster L. Restoring impaired protein metabolism in Parkinson's disease - TFEB-mediated autophagy as a novel therapeutic target. Mov. Disord. 2013, 28:1346.
99. Lapierre L.R., De Magalhaes Filho C.D., McQuary P.R., Chu C.C., Visvikis O., Chang J.T., et al. The TFEB orthologue HLH-30 regulated autophagy and modulated longevity in Caenorhabditis elegans. Nat. Commun. 2013, 4:2267.
100. Feeney E.J., Spampanato C., Puertollano R., Ballabio A., Parenti G., Raben N. What else is in store for autophagy? Exocytosis of autolysosomes as a mechanism of TFEB-mediated cellular clearance in Pompe disease. Autophagy 2013, 9:1117-1118.
101. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2011, 140:14.
102. Decressac M., Mattsson B., Weikop P., Lundblad M., Jakobsson J., Björklund A. TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity. Proc. Natl. Acad. Sci. U S A 2013, 110:E1817-E1826.
103. Uchida K., Unuma K., Funakoshi T., Aki T., Uemura K. Activation of master autophagy regulator TFEB during systemic lps administration in the cornea. J. Toxicol. Pathol. 2014, 27:153-158.
104. Spampanato C., Feeney E., Li L., Lim J.A., Annunziata F., Zare H., et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol. Med. 2013, 5:691-706.
105. Settembre C., Ballabio A. TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes. Autophagy 2011, 7:1379-1381.
106. Cortes C.J., Miranda H.C., Frankowski H., Batlevi Y., Young J.E., Le A., et al. Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat. Neurosci. 2014, 17:1180-1189.
107. Urbanelli L., Magini A., Ercolani L., Sagini K., Polchi A., Tancini B., et al. Oncogenic H-Ras upregulates acid beta-hexosaminidase by a mechanism dependent on the autophagy regulator TFEB. PLoS One 2014, 9:e89485.
108. Settembre C., Di Malta C., Polito V.A., Garcia Arencibia M., Vetrini F., Erdin S., et al. TFEB links autophagy to lysosomal biogenesis. Science 2011, 332:1429-1433.
109. Pastore N., Ballabio A., Brunetti-Pierri N. Autophagy master regulator TFEB induces clearance of toxic SERPINA1/alpha-1-antitrypsin polymers. Autophagy 2013, 9:1094-1096.
110. Pastore N., Blomenkamp K., Annunziata F., Piccolo P., Mithbaokar P., Maria Sepe R., et al. Gene transfer of master autophagy regulator TFEB results in clearance of toxic protein and correction of hepatic disease in alpha-1-anti-trypsin deficiency. EMBO Mol. Med. 2013, 5:397-412.
111. Chua J.P., Reddy S.L., Merry D.E., Adachi H., Katsuno M., Sobue G., et al. Transcriptional activation of TFEB/ZKSCAN3 target genes underlies enhanced autophagy in spinobulbar muscular atrophy. Hum. Mol. Genet. 2014, 23:1376-1386.
112. Martina J.A., Chen Y., Gucek M., Puertollano R. mTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 2012, 8:903-914.
113. Roczniak-Ferguson A., Petit C.S., Froehlich F., Qian S., Ky J., Angarola B., et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal 2012, 5:42.
114. David R. Autophagy: TFEB perfects multitasking. Nat. Rev. Mol. Cell Biol. 2011, 12:404.
115. Gallardo-Perez J.C., Espinosa M., Ceballos-Cancino G., Daniel A., Rodríguez-Enríquez S., Aviles A., et al. NF-kappa B is required for the development of tumor spheroids. J. Cell Biochem. 2009, 108:169-180.
116. Harikumar K.B., Sung B., Tharakan S.T., Pandey M.K., Joy B., Guha S., et al. Sesamin manifests chemopreventive affects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and antigenic gene products. Mol. Cancer Res. 2010, 8:751-761.
117. Benitez D.A., Hermoso M.A., Pozo-Guisado E., Fernández-Salguero P.M., Castellón E.A. Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expression in prostate cancer cells. Prostate 2009, 69:1045-1054.
118. Xu Y., Kong X., Zhou H., Zhang X., Liu J., Yan J., et al. oxLDL/beta2GPI/anti-beta2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway. Thromb. Res. 2014, 134:384-392.
119. Hernandez-Flores G., Ortiz-Lazareno P.C., Lerma-Diaz J.M., Dominguez-Rodriguez J.R., Jave-Suarez L.F., Aguilar-Lemarroy Adel C., et al. Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence. BMC Cancer 2011, 11:483.
120. Djavaheri-Mergny M., Amelotti M., Mathieu J., Besançon F., Bauvy C., Codogno P. Regulation of autophagy by NF-kappa B transcription factor and reactives oxygen species. Autophagy 2007, 3:390-392.
121. Schlottmann S., Buback F., Stahl B., Meierhenrich R., Walter P., Georgieff M., et al. Prolonged classical NF-kappa B activation prevents autophagy upon E. coli stimulation in vitro: a potential resolving mechanism of inflammation. Mediators Inflamm. 2008, 2008:725854.
122. Zhu B.S., Xing C.G., Lin F., Fan X.Q., Zhao K., Qin Z.H. Blocking NF-kappa B nuclear translocation leads to p53-related autophagy activation and cell apoptosis. World J. Gastroenterol. 2007, 17:478-487.
123. Hu W., Chen S.S., Zhang J.L., Lou X.E., Zhou H.J. Dihydroartemisinin induces autophagy by suppressing NF-kappa B activation. Cancer Lett. 2014, 343:239-248.
124. Wang W., Zhou J., Shi J., Zhang Y., Liu S., Liu Y., et al. Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis. J. Virol. 2014, 8:2786-2798.
125. Cui D.R., Wang L., Jiang W., Qi A.H., Zhou Q.H., Zhang X.L. Propofol prevents cerebral ischemia-triggered autophagy activation and cell death in the rat hippocampus through the NF-kappa B/p53 signaling pathway. Neuroscience 2014, 246:117-132.
126. Zhang J., Zhang Y., Liu S., Zhang Q., Wang Y., Tong L., et al. Metadherin confers chemoresistance of cervical cancer cells by inducing autophagy and activating ERK/NF-kappa B pathway. Tumour Biol. 2014, 34:2433-2440.
127. Shulak L., Beljanski V., Chiang C., Dutta S.M., Van Grevenynghe J., Belgnaoui S.M., et al. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-kappa B-dependent autophagy. J. Virol. 2014, 88:2927-2940.
128. Zeng M., Wei X., Wu Z., Li W., Li B., Zhen Y., et al. NF-kappa B-mediated induction of autophagy in cardiac ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 2013, 436:180-185.
129. Zhang Y., Wu Y., Wu D., Tashiro S., Onodera S., Ikejima T., et al. facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway. Arch. Biochem. Biophys. 2009, 489:25-33.
130. Lopez-Alonso I., Aguirre A., Gonzalez-Lopez A., Fernández ÁF, Amado-Rodríguez L., Astudillo A., et al. Impairment of autophagy decreases ventilator-induced lung injury by blockade of the NF-kappa B pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 2013, 304:L844-L852.
131. Barre B., Perkins N.D. The Skp2 promoter integrates signaling through the NF-kappa B, p53, and Akt/GSK3beta pathways to regulate autophagy and apoptosis. Mol. Cell 2010, 38:524-538.
132. Gupta M., Shin D.M., Ramakrishna L., Goussetis D.J., Platanias L.C., Xiong H., et al. IRF8 directs stress-induced autophagy in macrophages and promotes clearance of Listeria monocytogenes. Nat. Commun. 2013, 6:6379.
133. Liang S., Figtree G., Aiqun M., Ping Z. GAPDH-knockdown reduces rotenone-induced H9C2 cells death via autophagy and anti-oxidative stress pathway. Toxicol. Lett. 2015, 234:162-171.
134. Bhattacharya A., Eissa N.T. Autophagy as a stress response pathway in the immune system. Int. Rev. Immunol. 2015, [Epub ahead of print].
135. Yang Z., Zhong L., Zhong S., Xian R., Yuan B. Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model. Exp. Mol. Pathol. 2015, 98:219-224.
136. Kwon J.Y., Park B.S., Kim Y.H. Remifentanil protects human keratinocytes against hypoxia-reoxygenation injury through activation of autophagy. PLoS One 2015, 10:e0116982. 10.1371/journal.pone.0116982.
137. Wu J., Lei Z., Yu J. Hypoxia induces autophagy in human vascular endothelial cells in a hypoxia-inducible factor 1dependent manner. Mol. Med. Rep. 2015, 11:2677-2682.
138. Nanduri J., Vaddi D.R., Khan S.A., Wang N., Makarenko V., Semenza G.L., et al. HIF-1 alpha activation by intermittent hypoxia requires NADPH oxidase stimulation by xanthine oxidase. PLoS One 2015, 10:e0119762.
139. Shi H., Zheng B., Wu Y., Tang Y., Wang L., Gao Y., et al. Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1 alpha signaling under hypoxia. Oncol. Rep. 2015, 33:1185-1190.
140. Guan G., Zhang Y., Lu Y., Liu L., Shi D., Wen Y., et al. The HIF-1 alpha/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells. Cancer Lett. 2015, 357:254-264.
141. Thongchot S., Yongvanit P., Loilome W., Seubwai W., Phunicom K., Tassaneeyakul W., et al. High expression of HIF-1 alpha, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. Asian Pac. J. Cancer Prev. 2014, 15:5873-5878.
142. Wu Y., Li X., Xie W., Jankovic J., Le W., Pan T. Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem. Int. 2010, 57:198-205.
143. Sun Y., Xing X., Liu Q., Wang Z., Xin Y., Zhang P., et al. Hypoxia-induced autophagy reduces radio sensitivity by the HIF-1 alpha/miR-210/Bcl-2 pathway in colon cancer cells. Int. J. Oncol. 2015, 46:750-756.
144. Gong G., Hu L., Liu Y., Bai S., Dai X., Yin L., et al. Upregulation of HIF-1 alpha protein induces mitochondrial autophagy in primary cortical cell cultures through the inhibition of the mTOR pathway. Int. J. Mol. Med. 2014, 34:1133-1140.
145. Belibi F., Zafar I., Ravichandran K., Segvic A.B., Jani A., Ljubanovic D.G., et al. Hypoxia-inducible factor-1 alpha (HIF-1 alpha) and autophagy in polycystic kidney disease (PKD). Am. J. Physiol. Renal Physiol. 2011, 300:F1235-F1243.
146. Yang L., Tan P., Zhou W., Zhu X., Cui Y., Zhu L., et al. N-acetylcysteine protects against hypoxia mimetic-induced autophagy by targeting the HIF-1 alpha pathway in retinal ganglion cells. Cell. Mol. Neurobiol. 2012, 32:1275-1285.
147. Liu X.W., Su Y., Zhu H., Cao J., Ding W.J., Zhao Y.C., et al. HIF-1 alpha-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia. Pharmacol. Res. 2012, 62:416-425.
148. Sun L., Li T., Wei Q., Zhang Y., Jia X., Wan Z., et al. Upregulation of BNIP3 mediated by ERK/HIF-1 alpha pathway induces autophagy and contributes to anoikis resistance of hepatocellular carcinoma cells. Future Oncol. 2014, 10:1387-1398.
149. Zhao Y., Chen G., Zhang W., Xu N., Zhu J.Y., Jia J., et al. Autophagy regulates hypoxia-induced osteoclastogenesis through the HIF-1alpha/BNIP3 signaling pathway. J. Cell Physiol. 2012, 227:639-648.
150. Bohensky J., Leshinsky S., Srinivas V., Shapiro I.M. Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Intern. Med. J. 2011, 41:42-48.
151. Srinivas V., Bohensky J., Shapiro I.M., Autophagy: a new phase in the maturation of growth plate chondrocytes is regulated by HIF, mTOR and AMP kinase. Cells Tissues Organs 2009, 189:88-92.
152. Nepal S., Kim M.J., Hong J.T., Kim S.H., Sohn D.H., Lee S.H., et al. Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: Involvement of p53/FoxO3A axis. Oncotarget 2015, 6:7166-7181.
153. Mansilla S., Vizcaino C., Rodriguez-Sanchez M., Priebe W., Portugal J. Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells. J. Cell Mol. Med. 2015, 19:786-798.
154. Chakradeo S., Sharma K., Alhaddad A., Bakhshwin D., Le N., Harada H., et al. Yet another function of p53-the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective: implications for autophagy inhibition as a therapeutic strategy. Mol. Pharmacol. 2015, 87:803-814.
155. Lee H.Y., Chung K.J., Hwang I.H. Activation of p53 with ilimaquinone and ethylsmenoquinone marine sponge metabolites induces apoptosis and autophagy in colon cancer cells. Mar. Drugs 2015, 13:543-557.
156. Xiao J., Zhang T., Xu D., Wang H., Cai Y., Jin T., et al. FBXL20-mediated Vps34 ubiquitination as a p53 controlled checkpoint in regulating autophagy and receptor degradation. Genes Dev. 2015, 29:184-196.
157. Fan J.D., Lei P.J., Zheng J.Y., Wang X., Li S., Liu H., et al. The selective activation of p53 target genes regulated by SMYD2 in BIX-01294 induced autophagy-related cell death. PLoS One 2015, 10:e0116782.
158. Milan G., Romanello V., Pescatore F., Armani A., Paik J.H., Frasson L., et al. Regulation of autophagy and the ubiquitin-proteasome system by the FoxO transcriptional network during muscle atrophy. Nat. Commun. 2015, 6:6670.
159. Holmes F.A., Espina V., Liotta L.A., Nagarwala Y.M., Danso M., McIntyre K.J., et al. Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling. BMC Res. Notes 2013, 6:507.
160. Paula-Gomes S., Goncalves D.A., Baviera A.M., Zanon N.M., Navegantes L.C., Kettelhut I.C. Insulin suppresses atrophy- and autophagy-related genes in heart tissue and cardiomyocytes through AKT/FOXO signaling. Horm. Metab. Res. 2013, 45:849-855.
161. van der Vos K.E., Eliasson P., Proikas-Cezanne T., Vervoort S.J., van Boxtel R., Putker M., et al. Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. Nat. Cell Biol. 2012, 14:829-837.
162. Xu P., Das M., Reilly J., Davis R.J. JNK regulates FoxO-dependent autophagy in neurons. Genes Dev. 2011, 25:310-322.
163. Hariharan N., Maejima Y., Nakae J., Paik J., Depinho R.A., Sadoshima J. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 2010, 107:1470-1482.
164. Ferdous A., Battiprolu P.K., Ni Y.G., Rothermel B.A., Hill J.A. FoxO, autophagy, and cardiac remodeling. J. Cardiovasc. Transl. Res. 2010, 3:355-364.
165. Sengupta A., Molkentin J.D., Yutzey K.E. FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 2009, 284:28319-28331.
166. Benevolenskaya E.V., Frolov M.V. Emerging links between E2F control and mitochondrial function. Cancer Res. 2015, 75:619-623.
167. Sharma S., Sarkar J., Haldar C., Sinha S. Melatonin reverses Fas, E2F-1 and endoplasmic reticulum stress mediated apoptosis and dysregulation of autophagy induced by the herbicide atrazine in murine splenocytes. PLoS One 2015, 9:e108602.
168. Garcia-Garcia A., Rodriguez-Rocha H., Tseng M.T., Montes de Oca-Luna R., Zhou H.S., McMasters K.M., et al. E2F-1 lacking the transcriptional activity domain induces autophagy. Cancer Biol. Ther. 2012, 13:1091-1101.
169. Tracy K., Dibling B.C., Spike B.T., Knabb J.R., Schumacker P., Macleod K.F. BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol. Cell Biol. 2007, 27:6229-6242.
170. Wang F., Cho W.C., Chan L.W., Wong S.C., Tsui N.B., Siu P.M., et al. Gene network exploration of crosstalk between apoptosis and autophagy in chronic myelogenous leukemia. Biomed. Res. Int. 2015, 459840.
171. Sung Y.H., Jin Y., Kang Y., Devkota S., Lee J., Roh J.I., et al. Ei24, a novel E2F target gene, affects p53-independent cell death upon ultraviolet C irradiation. J. Biol. Chem. 2013, 288:31261-31267.
172. Lu H., Hallstrom T.C. The nuclear protein UHRF2 is a direct target of the transcription factor E2F1 in the induction of apoptosis. J. Biol. Chem. 2013, 288:23833-23843.
173. Haricharan S., Li Y. STAT signaling in mammary gland differentiation, cell survival and tumorigenesis. Mol. Cell Endocrinol. 2014, 382:560-569.
174. Liu K., Zhao E., Ilyas G., Lalazar G., Lin Y., Haseeb M., et al. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 2015, 11:271-284.
175. Huang Y., Huang X., Yang Y., Wang W., Yu Y., Qin Q. Involvement of fish signal transducer and activator of transcription 3 (STAT3) in nodavirus infection induced cell death. Fish Shellfish Immunol. 2015, 43:241-248.
176. McCormick J., Suleman N., Scarabelli T.M., Knight R.A., Latchman D.S., Stephanou A. STAT1 deficiency in the heart protects against myocardial infarction by enhancing autophagy. J. Cell Mol. Med. 2013, 16:386-393.
177. Knight R.A., Scarabelli T.M., Stephanou A., Scarabelli T.M., Abounit K., Latchman D.S., et al. STAT transcription in the ischemic heart. JAKSTAT 2012, 1:111-117.
178. McCormick J., Knight R.A., Barry S.P., Scarabelli T.M., Abounit K., Latchman D.S., et al. Autophagy in the stress-induced myocardium. Front. Biosci. 2012, 4:2131-2141.
179. Yan J., Wang Z.Y., Yang H.Z., Liu H.Z., Mi S., Lv X.X., et al. Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNgamma/STAT1-mediated activation of autophagy. PLoS One 2011, 6:e24705.
180. Kingsolver M.B., Huang Z., Hardy R.W. Insect antiviral innate immunity: pathways, effectors, and connections. J. Mol. Biol. 2013, 425:4921-4936.
181. Bhullar K.S., Rupasinghe H.P. Polyphenols: multipotent therapeutic agents in neurodegenerative diseases. Oxid. Med. Cell Longev. 2013, 891748.
182. Behringer C., Schwechheimer C. B-GATA transcription factors-insights into their structure, regulation, and role in plant development. Front. Plant Sci. 2015, 6:90.
183. McIver S.C., Kang Y.A., DeVilbiss A.W., O'Driscoll C.A., Ouellette J.N., Pope N.J., et al. The exosome complex establishes a barricade to erythroid maturation. Blood 2014, 124:2285-2297.
184. Banreti A., Lukacsovich T., Csikos G., Erdélyi M., Sass M. PP2A regulates autophagy in two alternative ways in Drosophila. Autophagy 2012, 8:623-636.
185. Füllgrabe J., Klionsky D.J., Joseph B. The return of nucleus: transcriptional and epigenetic control of autophagy. Nat. Rev. Mol. Cell. Biol. 2014, 15:65-74.
186. Jin M., Klionsky D.J. Regulation of autophagy: modulation of the size and number of autophagosomes. FEBS Lett. 2014, 588:2457-2463.